Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Medicare announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic and Wegovy ...

N-Power Medicine, backed by Merck GHI, announced the acquisition of Syapse Holdings. Samsung Biologics and LigaChem extended their ADC services deal. Publicis Worldwide merged with Leo Burnett to form ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...

The lawsuit filed Thursday in Marion County Superior Court accuses Mylan and Pfizer of conspiring to raise the price of ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

Lilly is considering expanding the availability of lower-priced vials of its blockbuster obesity drug Zepbound ...

New York, New York-- (Newsfile Corp. - January 16, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and ...

A New York Supreme Court judge dismissed a lawsuit by New York City against Exxon, BP, and Shell alleging they misled the ...

Lilly Pulitzer is serving up a Valentine’s Day partnership with Lele Sadoughi, the New York-based accessories brand. Marking ...

Columbus joins the states of Arkansas, California, Kansas, Kentucky, Minnesota and Mississippi and other cities and counties ...